Patents by Inventor Gina Marie Geiselman

Gina Marie Geiselman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically modified fungal cells and methods useful for producing prespatane
    Patent number: 11845940
    Abstract: The present invention provides for a genetically modified fungal host cell capable of producing prespatane and/or epi-isozizaene comprising prespatane synthase (PPS) and/or epi-isozizaene synthase (EIZS).
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: December 19, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
    Inventors: Gina Marie Geiselman, James Kirby, Taek Soon Lee, John M. Gladden, Blake A. Simmons
  • Methods of producing lipid-derived compounds and host cells thereof
    Patent number: 11560576
    Abstract: The present disclosure relates to genetically engineered host cells and methods of producing a lipid-derived compound by employing such host cells. In particular embodiments, the host cell includes a first mutant gene encoding a cytoplasmic tRNA thiolation protein. Optionally, the host cell can include other mutant genes for decreasing fatty alcohol catabolism, decreasing re-importation of secreted fatty alcohol, or displaying other useful characteristics, as described herein.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: January 24, 2023
    Assignee: National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Samuel Coradetti, John Michael Gladden, Di Liu, Gina Marie Geiselman
  • GENETICALLY MODIFIED FUNGAL CELLS AND METHODS USEFUL FOR PRODUCING PRESPATANE
    Publication number: 20210269810
    Abstract: The present invention provides for a genetically modified fungal host cell capable of producing prespatane and/or epi-isozizaene comprising prespatane synthase (PPS) and/or epi-isozizaene synthase (EIZS).
    Type: Application
    Filed: February 26, 2021
    Publication date: September 2, 2021
    Inventors: Gina Marie Geiselman, James Kirby, Taek Soon Lee, John M. Gladden, Blake A. Simmons